SCHEMBL32679073

SCHEMBL32679073

CC(C)(C)[Si](C)(C)O[C@H]1[C@@H](O[PH](=O)O)[C@H](n2cc(F)c3c(=O)[nH]cnc32)O[C@H]1COP(=S)(OCCC#N)O[C@H]1[C@@H](F)[C@@H](n2cnc3c(NC(=O)c4ccccc4)ncnc32)O[C@@H]1CO

nearest known ligand 0.39

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ P2RY12 Q9H244 10/20 0.34
▸ PRMT6 Q96LA8 1/20 0.33
▸ ADORA1 P30542 2/20 0.32
▸ P2RX3 P56373 1/20 0.32
▸ P2RX4 Q99571 1/20 0.32
▸ P2RX2 Q9UBL9 1/20 0.32
▸ P2RY2 P41231 1/20 0.32
▸ P2RY1 P47900 1/20 0.32
▸ P2RY6 Q15077 1/20 0.32
▸ DNPH1 O43598 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32679076 1.00 P2RY12 (0.34) P2RY12PRMT6ADORA1P2RX3P2RX4
SCHEMBL20214132 1.00 P2RY12 (0.34) P2RY12PRMT6ADORA1P2RX3P2RX4
SCHEMBL32679094 0.97 P2RY12 (0.35) P2RY12PRMT6ADORA1P2RX3P2RX4
SCHEMBL20214641 0.97 P2RY12 (0.35) P2RY12PRMT6ADORA1P2RX3P2RX4
SCHEMBL32679090 0.97 P2RY12 (0.35) P2RY12PRMT6ADORA1P2RX3P2RX4
SCHEMBL31637489 0.97 P2RY12 (0.35) P2RY12PRMT6ADORA1P2RX3P2RX4
SCHEMBL20214158 0.96 P2RY12 (0.35) P2RY12PRMT6ADORA1P2RX3P2RX4
SCHEMBL21137642 0.96 P2RY12 (0.35) P2RY12PRMT6ADORA1P2RX3P2RX4
SCHEMBL23228178 0.94 P2RY12 (0.36) P2RY12ADORA1P2RY2P2RY1P2RY6
SCHEMBL21137213 0.94 P2RY12 (0.35) P2RY12PRMT6ADORA1P2RX3P2RX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3868384-B1 CYCLIC DINUCLEOTIDES AS STING (STIMULATOR OF INTERFERON GENES) AGONISTS TAKEDA PHARMACEUTICALS CO (JP) 2026-02-25 — — EP disclosed
Send feedback